𝔖 Bobbio Scriptorium

✦ LIBER ✦

Re: Agarwal A et al.: The Safety and Efficacy of Different Doses of Bacillus Calmette Guerin in Superficial Bladder Transitional Cell Carcinoma (Urology 2007;70:1075-1078)

✍ Scribed by Madhu S. Agrawal; Sumit Bansal

Book ID: 116949235
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 73
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2008.02.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Agrawal et al.: The Safety and Effic

Re: Agrawal et al.: The Safety and Efficacy of Different Doses of Bacillus Calmette-Guérin in Superficial Bladder Transitional Cell Carcinoma. (Urology 2007;70:1075–1078)

✍ Giuseppe Simone; Costantino Leonardo; Michele Gallucci 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The Safety and Efficacy of Different Dos

The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma

✍ Madhu S. Agrawal; Moneet Agrawal; Sumit Bansal; Mayank Agarwal; Prashant Lavania 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Re: Richard J. Sylvester, Maurizio A. Br

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Tommaso Cai; Lorenzo Giuseppe Luciani; Gianni Malossini 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Reply to Tomasso Cai, Lorenzo Giuseppe L

Reply to Tomasso Cai, Lorenzo Giuseppe Luciani and Gianni Malossini's Letter to the Editor re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Richard J. Sylvester; Maurizio A. Brausi; Ziya Kirkali; Theo M. de Reijke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB